Heidi Klepin to Hematopoietic Stem Cell Transplantation
This is a "connection" page, showing publications Heidi Klepin has written about Hematopoietic Stem Cell Transplantation.
Connection Strength
0.662
-
Yates SJ, Lyerly S, Manuel M, Tooze JA, Klepin HD, Powell BL, Dralle S, Uprety A, Pardee TS. The prognostic value of standardized phase angle in adults with acute leukemia: A prospective study. Cancer Med. 2020 04; 9(7):2403-2413.
Score: 0.167
-
Lin RJ, Klepin HD. Evidence-Based Minireview: Longitudinal geriatric assessment in quality care for older patients with hematologic malignancies. Hematology Am Soc Hematol Educ Program. 2019 12 06; 2019(1):59-62.
Score: 0.165
-
Klepin HD. Definition of Unfit for Standard Acute Myeloid Leukemia Therapy. Curr Hematol Malig Rep. 2016 12; 11(6):537-544.
Score: 0.134
-
Ahmed T, Holwerda S, Klepin HD, Isom S, Ellis LR, Lyerly S, Manuel M, Dralle S, Berenzon D, Powell BL, Pardee TS. High dose cytarabine, mitoxantrone and l-asparaginase (HAMA) salvage for relapsed or refractory acute myeloid leukemia (AML) in the elderly. Leuk Res. 2015 Sep; 39(9):945-9.
Score: 0.121
-
Wildes TM, Tuchman SA, Klepin HD, Mikhael J, Trinkaus K, Stockerl-Goldstein K, Vij R, Colditz G. Geriatric Assessment in Older Adults with Multiple Myeloma. J Am Geriatr Soc. 2019 05; 67(5):987-991.
Score: 0.039
-
Michaelis LC, Klepin HD, Walter RB. Advancements in the management of medically less-fit and older adults with newly diagnosed acute myeloid leukemia. Expert Opin Pharmacother. 2018 06; 19(8):865-882.
Score: 0.037